Last year biotech venture capital investing began to recover from its 2009 low, growing three percent in the number of dollars raised and eight percent in the number of deals which were struck. That represents a significant bounce-back from 2009, which saw biotech investing plummet 19 percent during the worst of the economic crisis.
With the help of data provided by the National Venture Capital Association, we've compiled a list of the promising biotech companies which were the most successful at raising money in 2010. Our top VC earner in 2010--Pacific Biosciences--is making its last appearance on this list; the sequencing compan
To read the full, original article click on this link: Top 15 Biotech Venture Capital Deals of 2010 - FierceBiotech
Author: Maureen Martino, Liz Jones-Hollis and Erica Teichert